Lilly/Boehringer Ingelheim's insulin glargine product will be available in a pre-filled pen and cartridges for a reusable pen. The marketing authorisation for the Alliance's insulin glargine ...

Objective — To determine the pharmacokinetic and pharmacodynamic dose-response effects of insulin glargine administered subcutaneously in individuals with type 2 diabetes. Research design and ...

Original Medicare (Part A and Part B) does not cover insulin glargine (Basagalar ... acting insulin medication delivered through insulin pens called KwikPens. Basaglar is a brand-name drug ...